Two threshold levels of vitamin D and the prevalence of comorbidities in outpatients of a tertiary hospital
This study evaluated the number of comorbidities between two normal values of 25OHD in outpatients during 1 year of 25OHD measurements. Five hundred twenty-nine outpatients were included, patients with 25OHD ≥ 20 and < 30 ng/mL had the higher number of comorbidities, suggesting that for this specific population, 25OHD ≥ 30 ng/mL would be more appropriate.
This study evaluated the comorbidities between two values of 25OHD in outpatients of a tertiary hospital.
This is a cross-sectional study with measures of 25OHD in 1-year period, excluding 25OHD < 20 and > 50 ng/mL, clinical research participants, and liver disease and chronic renal failure patients. Patients were divided into two groups: group 1 (G1), 25OHD ≥ 20 and < 30 ng/mL; and group 2 (G2), 250HD ≥ 30 and ≤ 50 ng/mL. Medical records were reviewed for demographic, laboratory, and comorbidity data.
From 529 outpatients included, 319 were in G1 (53.3 ± 15.8 years, 85% women), mean 25OHD 24.8 ± 2.8 ng/mL; and 210 outpatients in G2 (56.7 ± 16.0 years, 83% women), mean 25OHD was 36.8 ± 4.8 ng/mL. G1 had the higher number of comorbidities, including altered glycemia, dyslipidemia, hypothyroidism, urinary tract diseases, arthropathy, secondary hyperparathyroidism, anemia, and neurological and psychiatric disorders. Osteoporosis and hypothyroidism were more prevalent in G2. After binary logistic regression, the variables age (OR 0.988, CI 0.97–1.00, p = 0.048), osteoporosis (OR 0.54, CI 0.36–0.80, p = 0.003), dyslipidemia (OR 1.61, CI 1.10–2.39, p = 0.015), arthropathy (OR 2.60, CI 1.40–5.10, p = 0.003), anemia (OR 15.41, CI 3.09–280.08, p = 0.008), and neurological and psychiatric diseases (OR 3.78, CI 1.98–7.88, p = 0.001) maintained significance.
Patients with serum 25OHD ≥ 20 and < 30 ng/mL had higher prevalence of comorbidities compared to ≥ 30 ng/mL.
KeywordsComorbidities Deficiency Outpatients Vitamin D Vitamin D threshold
Compliance with ethical standards
The study was approved by the research ethics committee (CEP-HC-UFPR), 46017715.0.3001.0096.
Conflict of interest
- 1.Maeda SS, Saraiva GL, Hayashi LF, Cendoroglo MS, Ramos LR, Corrêa Mde P, Henrique de Mesquita C, Lazaretti-Castro M (2013) Seasonal variation in the serum 25-hydroxyvitamin D levels of young and elderly active and inactive adults in São Paulo, Brazil: The São PAulo Vitamin D Evaluation Study (SPADES). Dermatoendocrinol 5(1):211–217. https://doi.org/10.4161/derm.24476 CrossRefPubMedPubMedCentralGoogle Scholar
- 3.Mithal A, Wahl DA, Bonjour JP, Burckhardt P, Dawson-Hughes B, Eisman JA, El-Hajj Fuleihan G, Josse RG, Lips P, Morales-Torres J (2009) IOF Committee of Scientific Advisors (CSA) Nutrition Working Group. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int 20(11):1807–1820. https://doi.org/10.1007/s00198-009-0954-6 CrossRefGoogle Scholar
- 4.Arantes HP, Kulak CAM, Fernandes CE, Zerbini C, Bandeira F, Barbosa IC, Brenol JCT, Russo LA, Borba VC, Chiang AY, Bilezikian JP, Lazaretti-Castro M (2013) Correlation between 25-hydroxyvitamin D levels and latitude in Brazilian postmenopausal women: from the Arzoxifene Generations Trial. Osteoporos Int 24(10):2707–2712. https://doi.org/10.1007/s00198-013-2366-x CrossRefPubMedGoogle Scholar
- 5.Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium; Ross AC, Taylor CL, Yaktine AL, et al editors (2011) Dietary reference intakes for calcium and vitamin D. Washington (DC): National Academies Press (US). Available from: https://www.ncbi.nlm.nih.gov/books/NBK56070/. doi: 10.17226/13050
- 15.Neuerburg C, Mittlmeier L, Schmidmaier R, Kammerlander C, Böcker W, Mutschler W, Stumpf U (2017) Investigation and management of osteoporosis in aged trauma patients: a treatment algorithm adapted to the German guidelines for osteoporosis. J Orthop Surg Res 12(1):86. https://doi.org/10.1186/s13018-017-0585-0 CrossRefPubMedPubMedCentralGoogle Scholar
- 21.Anderson JL, May HT, Horne BD, Bair TL, Hall NL, Carlquist JF, Lappé DL, Muhlestein JB, Intermountain Heart Collaborative (IHC) Study Group (2010) Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol 106(7):963–968. https://doi.org/10.1016/j.amjcard.2010.05.027 CrossRefPubMedGoogle Scholar
- 22.Martins D, Wolf M, Pan D, Zadshir A, Tareen N, Thadhani R, Felsenfeld A, Levine B, Mehrotra R, Norris K (2007) Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 167(11):1159–1165. https://doi.org/10.1001/archinte.167.11.1159 CrossRefPubMedGoogle Scholar
- 23.Guasch A, Bulló M, Rabassa A, Bonada A, Del Castillo D, Sabench F, Salas-Salvadó J (2012) Plasma vitamin D and parathormone are associated with obesity and atherogenic dyslipidemia: a cross-sectional study. Cardiovasc Diabetol 11:149. https://doi.org/10.1186/1475-2840-11-149 CrossRefPubMedPubMedCentralGoogle Scholar
- 28.Mitri J, Dawson-Hughes B, Hu FB, Pittas AG (2011) Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr 94(2):486–494. https://doi.org/10.3945/ajcn.111.011684 CrossRefPubMedPubMedCentralGoogle Scholar
- 30.Mason C, Xiao L, Imayama I, Duggan CR, Bain C, Foster-Schubert KE, Kong A, Campbell KL, Wang CY, Neuhouser ML, Li L, W Jeffery R, Robien K, Alfano CM, Blackburn GL, McTiernan A (2011) Effects of weight loss on serum vitamin D in postmenopausal women. Am J Clin Nutr 94(1):95–103. https://doi.org/10.3945/ajcn.111.015552 CrossRefPubMedPubMedCentralGoogle Scholar
- 35.Bičíková M, Dušková M, Vítků J, Kalvachová B, Řípová D, Mohr PSL (2015) Vitamin D in anxiety and affective disorders. Physiol Res 64(Suppl 2):101–103Google Scholar
- 36.Kjærgaard M, Waterloo K, Wang CE, Almås B, Figenschau Y, Hutchinson MS, Svartberg J, Jorde R (2012) Effect of vitamin D supplement on depression scores in people with low levels of serum 25-hydroxyvitamin D: nested case-control study and randomised clinical trial. Br J Psychiatry 201(5):360–368. https://doi.org/10.1192/bjp.bp.111.104349 CrossRefPubMedGoogle Scholar
- 38.Maeda SS, Borba VZ, Camargo MB, Silva DM, Borges JL, Bandeira F, Lazaretti-Castro M, Brazilian Society of Endocrinology and Metabology (SBEM) (2014) Recommendations of the Brazilian Society of Endocrinology and Metabology (SBEM) for the diagnosis and treatment of hypovitaminosis D. Arq Bras Endocrinol Metabol 58(5):411–433CrossRefGoogle Scholar